iSpecimen Inc. (ISPC)
1.82
-0.08 (-4.21%)
At close: Feb 20, 2025, 3:59 PM
1.84
1.10%
After-hours: Feb 20, 2025, 05:52 PM EST
undefined% (undefined)
| Bid | 1.78 |
| Market Cap | 1.75M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -18.12 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.87 |
| Volume | 64,389 |
| Avg. Volume (20D) | 527,927 |
| Open | 1.91 |
| Previous Close | 1.90 |
| Day's Range | 1.80 - 1.90 |
| 52-Week Range | 1.76 - 11.80 |
| Beta | undefined |
About ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Mark...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 17, 2021
Employees 53
Stock Exchange NASDAQ
Ticker Symbol ISPC
Website https://ispecimen.com
Next Earnings Release
iSpecimen Inc. is scheduled to release its earnings on Mar 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+7.95%
ISpecimen shares are trading higher after the comp...
Unlock content with
Pro Subscription
5 months ago
-23.14%
iSpecimen shares are trading lower after the company announced a 1-for-20 reverse stock split.
2 months ago · newsfilecorp.com
iSpecimen Will Serve as a Preferred Provider of Cancer BiospecimensWoburn, Massachusetts--(Newsfile Corp. - December 20, 2024) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, today announced its strategic initiatives for 2025, ex...
